Clinical trial

Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height…

NCT00001221 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00001221
Title Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
Official title A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Gonadal Dysgenesis, Turner's Syndrome
Intervention type Drug
Interventions Growth Hormone (Humatrope)
Enrollment 160
Start date Sep 1, 1987
Completion Sep 1, 2003
First posted Nov 4, 1999
Last update posted Mar 4, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies